8-K
filed November 13, 2025, 6:59 PM ET
ticker PTHS
CIK 0001919246
earnings
confidence high
sentiment neutral
materiality 0.65
Pelthos Q3: ZELSUVMI launch generates $7.1M net revenue, net loss $16.2M
Pelthos Therapeutics Inc.
2025-Q3 EPS
reported -$14.96
vs consensus -$0.44
▼ miss
(-3310.9%)
- Net product revenue of $7.1M from ZELSUVMI in first commercial quarter (Q3 ended Sep 30, 2025).
- 2,716 units prescribed by 1,169 unique prescribers; October alone saw 2,189 units prescribed.
- Net loss of $16.2M ($5.30 per basic/diluted share); as-converted net loss of $1.83/share.
- Cash of $14.2M at Sep 30, 2025; closed $18M convertible notes financing in Nov 2025.
- Completed acquisition of XEPI (FDA-approved impetigo treatment) in Nov 2025, adding complementary dermatology product.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001753926-25-001766
- form_type
- 8-K
- ticker
- PTHS
- cik
- 0001919246
- company_name
- Pelthos Therapeutics Inc.
- filed_at
- 2025-11-13T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:41.061601+00:00
- generated_at
- 2026-05-16T20:36:53.501363+00:00
- sec_items
- ["2.02", "7.01", "9.01"]
- event_type
- earnings
- sentiment
- neutral
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001753926-25-001766
- json_url
- https://secwatch.observer/filing/0001753926-25-001766.json
- markdown_url
- https://secwatch.observer/filing/0001753926-25-001766.md
- text_url
- https://secwatch.observer/filing/0001753926-25-001766.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1919246/000175392625001766/0001753926-25-001766-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1919246/000175392625001766/g085015_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
FNGR
FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M
FingerMotion, Inc.
May 29, 2026, 5:12 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
ADSK
Autodesk Q1 FY27 revenue up 18% to $1.93B, GAAP EPS $2.32; acquires MaintainX
Autodesk, Inc.
May 28, 2026, 4:14 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
OKTA
Okta Q1 FY2027 rev $765M (+11% YoY); GAAP net income $74M; free cash flow $271M
Okta, Inc.
May 28, 2026, 4:03 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SOTK
Sono-Tek reports FY2026 net income up 42% to $1.8M; gross margin expands to 51%
SONO TEK CORP
May 28, 2026, 7:10 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
KSS
Kohl's Q1 net loss $14M; comparable sales down 1.1% YoY; affirms FY outlook
KOHLS Corp
May 28, 2026, 7:00 AM ET
earnings
Items 2.02, 7.01, 8.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
DLTR
Dollar Tree Q1 net sales +7.2%, comp +3.5%, adj EPS $1.74 (+38%), raises FY guidance
DOLLAR TREE, INC.
May 28, 2026, 6:31 AM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
BBWI
BBWI Q1 sales down 3%, adjusted EPS $0.32 beats guidance; CFO Boratto to step down June 12
Bath & Body Works, Inc.
May 27, 2026, 7:12 AM ET
earnings
Items 2.02, 7.01, 5.02, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SMTC
Semtech reports record Q1 net sales $291M, GAAP EPS $0.27, adjusted EPS $0.51
SEMTECH CORP
May 26, 2026, 4:07 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 7.01, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.